Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
In BriefThis Month in JNM

This Month in JNM

Journal of Nuclear Medicine July 2015, 56 (7) 9A;
  • Article
  • Info & Metrics
  • PDF
Loading

PET and aortic aneurysm: Rudd and colleagues provide an overview of PET in aortic aneurysm, with a focus on the ability of imaging to predict expansion, and preview a related article in this issue of JNM.

Page 971

Calcium in noncalcified lesions: Strauss and Narula look at the pathophysiology of atheroma, the clinical significance of intimal arterial calcification, and an article in this issue of JNM on serial 18F-NaF vascular imaging in this setting.

Page 974

Retention of 177Lu/177mLu-DOTATATE: Sjögreen Gleisner and colleagues investigate long-term activity retention of radionuclides from peptide receptor therapy dosimetry and discuss the implications for timing of postdosimetry imaging.

Page 976

Quantifying SPECT uptake: Rowe and colleagues report on the variability of normal abdominal organ uptake values in serial 111In-pentetreotide SPECT studies in patients with neuroendocrine or carcinoid tumors.

Page 985

PET/CT follow-up in colorectal cancer: Marcus and colleagues explore the added value of a fourth and subsequent follow-up PET/CT scans in clinical assessment and patient management after primary treatment for colorectal cancer.

Page 989

PET vs. PET/CT in esophageal cancer: Goense and colleagues provide a metaanalysis of the performance of 18F-FDG PET and integrated 18F-FDG PET/CT in diagnosing recurrent esophageal cancer after initial treatment with curative intent.

Page 995

18F-DCFBC PET in primary prostate cancer: Rowe and colleagues evaluate PET imaging with this prostate-specific membrane antigen–targeting tracer in men undergoing definitive surgery and correlate results with those from pelvic MR imaging and pathology.

Page 1003

Mortality prediction in heart failure: Narula and colleagues apply multiple multivariate risk modeling techniques to determine the independent prognostic ability of 123I-MIBG imaging for mortality outcomes in individuals with heart failure.

Page 1011

NaF uptake in atherosclerotic plaque: Fiz and colleagues use PET/CT to look at vascular 18F-NaF uptake in plaque of 3 different densities and discuss possibilities for molecular assessment of calcium deposition in early stages of plaque formation.

Page 1019

Therapy control in graft infections: Husmann and colleagues report on the clinical value of 18F-FDG PET/CT for therapy control and management in patients with prosthetic vascular graft infections.

Page 1024

PET/CT in AAA: Morel and colleagues describe the results of an analysis of serial 18F-FDG PET imaging of rates of growth in medically treated abdominal aortic aneurysms and of metabolic parameters of associated parietal inflammation.

Page 1030

Midbrain function in PD: Joutsa and colleagues use 123I-FP-CIT SPECT to elucidate midbrain dopaminergic projections and extrastriatal serotonergic abnormalities in patients with Parkinson disease.

Page 1036

Voxelwise parameter correlations and Aβ load: Sojkova and colleagues use 15O-H2O and 11C-PiB PET to research local relationships between distribution volume ratio, cerebral blood flow, and amyloid-β load in nondemented older adults.

Page 1042

Quantifying inflammation in neurodegeneration: Lavisse and colleagues assess 18F-DPA-714 PET in healthy translocator protein–genotyped volunteers and explore a method designed to eliminate the need for invasive arterial blood sampling.

Page 1048

Enhancing T cell imaging sensitivity: Moroz and colleagues focus on human reporter gene systems and the minimum numbers of T cells that can be visualized with different nuclear reporter systems and PET or SPECT imaging.

Page 1055

MR AC in PET/MR: Paulus and colleagues detail a novel model-based attenuation correction method that improves PET quantification of bone and nearby soft tissue in whole-body hybrid PET/MR imaging.

Page 1061

Pediatric PET/MR AC: Bezrukov and colleagues assess the impact of 2 potentially influential factors—inter- and intrapatient variability of attenuation coefficients and anatomic variability—in PET/MR imaging in children.

Page 1067

GLP-1 receptor PET/CT: Antwi and colleagues determine whether PET/CT imaging with a novel 68Ga-labeled glucagonlike peptide-1 receptor–targeting agent is feasible and sensitive in detecting benign insulinomas and compare results with those from 111In-DOTA-exendin-4 SPECT/CT.

Page 1075

Current developments in radioembolization: Braat and colleagues provide an educational overview of indications and approaches in radioembolization, with a focus on patient selection, recent developments, and future applications.

Page 1079

64Cu-FBP8 and DVT-PE imaging: Blasi and colleagues explore the feasibility of 64Cu-FBP8 PET for detecting source thrombi and culprit emboli after deep vein thrombosis and pulmonary embolism and offer human dosimetry estimations.

Page 1088

Anti-PSMA Nanobody: Chatalic and colleagues describe the development of initial studies with a novel anti–prostate-specific membrane antigen Nanobody for targeted SPECT/CT imaging and therapy of prostate cancer.

Page 1094

Kit-producible 18F-SiFAlin: Niedermoser and colleagues research the in vivo properties of good manufacturing practice–compliant and “kitlike producible” 18F-SiFA– and 18F-SiFAlin–modified TATE derivatives for PET imaging in somatostatin receptor–bearing tumors.

Page 1100

Liposomal therapy and 18F-FDG PET: Hwang and colleagues assess delivery of angiogenic peptides with vascular endothelial growth factor in cerebral ischemia and explore the potential of 18F-FDG PET imaging in an animal model of ischemic stroke treatment.

Page 1106

Monitoring oncogene expression: Mendler and colleagues report on a comparison of 89Zr and 124I in labeling of the recombinant αHER2 Fab-PAS200 protein tracer for immuno-PET imaging of HER2-positive human xenograft tumors in mice.

Page 1112

Targeted radionuclide therapy workshop: Fahey and colleagues summarize the proceedings of a second joint SNMMI/National Cancer Institute expert meeting on current developments and future potential for targeted radionuclide therapy, held in October 2014.

Page 1119

  • © 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 56 (7)
Journal of Nuclear Medicine
Vol. 56, Issue 7
July 1, 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
This Month in JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
This Month in JNM
Journal of Nuclear Medicine Jul 2015, 56 (7) 9A;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
This Month in JNM
Journal of Nuclear Medicine Jul 2015, 56 (7) 9A;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • Diagnostic Performance of 18F-FDG PET and PET/CT for the Detection of Recurrent Esophageal Cancer After Treatment with Curative Intent: A Systematic Review and Meta-Analysis
  • Whole-Body PET/MR Imaging: Quantitative Evaluation of a Novel Model-Based MR Attenuation Correction Method Including Bone
  • A Novel 111In-Labeled Anti–Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer
  • Long-Term Retention of 177Lu/177mLu-DOTATATE in Patients Investigated by γ-Spectrometry and γ-Camera Imaging
  • Finding Calcium in Noncalcified Lesions: 18F-Fluoride Offers Insights into Atheroma Evolution
  • Localization of Hidden Insulinomas with 68Ga-DOTA-Exendin-4 PET/CT: A Pilot Study
  • 18F-NaF Uptake by Atherosclerotic Plaque on PET/CT Imaging: Inverse Correlation Between Calcification Density and Mineral Metabolic Activity
  • 18F-FDG PET/CT and Colorectal Cancer: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management
  • Proceedings of the Second NCI–SNMMI Workshop on Targeted Radionuclide Therapy
  • 89Zr-Labeled Versus 124I-Labeled αHER2 Fab with Optimized Plasma Half-Life for High-Contrast Tumor Imaging In Vivo
  • 123I-MIBG Imaging for Prediction of Mortality and Potentially Fatal Events in Heart Failure: The ADMIRE-HFX Study
  • 18F-FDG PET/CT for Therapy Control in Vascular Graft Infections: A First Feasibility Study
  • Quantitative Evaluation of Segmentation- and Atlas-Based Attenuation Correction for PET/MR on Pediatric Patients
  • 90Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments
  • Voxelwise Relationships Between Distribution Volume Ratio and Cerebral Blood Flow: Implications for Analysis of β-Amyloid Images
  • Comparative Analysis of T Cell Imaging with Human Nuclear Reporter Genes
  • Evidence of Cyclic Changes in the Metabolism of Abdominal Aortic Aneurysms During Growth Phases: 18F-FDG PET Sequential Observational Study
  • 18F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer
  • Optimized Quantification of Translocator Protein Radioligand 18F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers
  • Dorsal-to-Ventral Shift in Midbrain Dopaminergic Projections and Increased Thalamic/Raphe Serotonergic Function in Early Parkinson Disease
  • Predicting Aortic Aneurysm Expansion by PET
  • In Vivo Evaluation of 18F-SiFAlin–Modified TATE: A Potential Challenge for 68Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET
  • Radiation Dosimetry of the Fibrin-Binding Probe 64Cu-FBP8 and Its Feasibility for PET Imaging of Deep Vein Thrombosis and Pulmonary Embolism in Rats
  • Improving Cerebral Blood Flow Through Liposomal Delivery of Angiogenic Peptides: Potential of 18F-FDG PET Imaging in Ischemic Stroke Treatment
  • Repeatability of Radiotracer Uptake in Normal Abdominal Organs with 111In-Pentetreotide Quantitative SPECT/CT
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire